A New Era in Treating Advanced Ovarian Cancer Practical Tips for Maximizing the Use of PARP Inhibitors, ADCs, and Other Emerging Targeted Approaches
- Provider:PVI, PeerView Institute for Medical Education
- Activity Link: https://www.peerview.com/UYH
- Start Date: 2025-03-15 05:00:00
- End Date: 2025-03-15 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABIM - 1.0 Point; Credit Type(s): Patient Safety (ABIM) - Commercial Support: Source: AstraZeneca (Any division) - Amount: 0 - Is Kind Support: False Source: Merck (Any division) - Amount: 0 - Is Kind Support: False Source: Sutro Biopharma - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest